Ian T. Magrath
#127,589
Most Influential Person Now
Ian T. Magrath's AcademicInfluence.com Rankings
Ian T. Magrathphilosophy Degrees
Philosophy
#6042
World Rank
#9005
Historical Rank
Logic
#3233
World Rank
#4360
Historical Rank
Download Badge
Philosophy
Why Is Ian T. Magrath Influential?
(Suggest an Edit or Addition)Ian T. Magrath's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. (1995) (1068)
- p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. (1991) (939)
- Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. (1996) (483)
- The pathogenesis of Burkitt's lymphoma. (1990) (482)
- p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. (1994) (453)
- Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma. (1980) (420)
- Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. (1997) (398)
- Lymphocyte depletion during treatment with intensive chemotherapy for cancer. (1994) (383)
- Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. (1986) (350)
- Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. (1993) (329)
- Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis. (1979) (306)
- Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults. (1987) (303)
- Paediatric cancer in low-income and middle-income countries. (2013) (295)
- Point mutations in the c–Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas (1993) (273)
- Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association. (1991) (268)
- Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma. (1988) (250)
- An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults. (1984) (248)
- Binding and suppression of the Myc transcriptional activation domain by p107. (1994) (229)
- Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive study. (2008) (228)
- A chemiluminescent assay for quantitation of β-galactosidase in the femtogram range: Application to quantitation of β-galactosidase in lacZ-transfected cells (1991) (211)
- African Burkitt's lymphoma. History, biology, clinical features, and treatment. (1991) (185)
- The American Burkitt's lymphoma registry: Eight years' experience (1982) (174)
- Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma [see comments] (1991) (168)
- Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival. (1987) (162)
- Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas. (1981) (162)
- Malignant non-Hodgkin's lymphomas in children. (1987) (153)
- Epidemiology: clues to the pathogenesis of Burkitt lymphoma (2012) (151)
- Pediatric Oncology in Countries with Limited Resources (1997) (148)
- Polyclonal immunoglobulin secretion by human B lymphocytes exposed to Epstein-Barr virus in vitro. (1979) (148)
- Diversity of immunological phenotypes of lymphoblastic lymphoma. (1983) (147)
- Prolonged complete remission following high dose chemotherapy of burkitt's lymphoma in relapse (1978) (146)
- The Non-Hodgkin's lymphomas (1990) (143)
- Cancer in developing countries: opportunity and challenge. (1993) (142)
- Surgical Reduction of Tumour Bulk in Management of Abdominal Burkitt's Lymphoma (1974) (137)
- Plasma lipid alterations in leukemia and lymphoma. (1982) (129)
- Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: high prevalence of p53 overexpression. (1999) (126)
- Childhood Hodgkin's disease in Uganda. A ten year experience (1978) (126)
- The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors. (1992) (124)
- Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas. (1996) (122)
- A Multidisciplinary Approach to Non-Hodgkin's Lymphomas (1981) (114)
- Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus. (1983) (113)
- Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year peroid (2005) (112)
- B cell differentiation and immunoregulatory T cell function in human cord blood lymphocytes. (1980) (110)
- New policies to address the global burden of childhood cancers. (2013) (105)
- Essential drugs for cancer therapy: a World Health Organization consultation. (1999) (105)
- Relationship between DNA cross-links, cell cycle, and apoptosis in Burkitt's lymphoma cell lines differing in sensitivity to nitrogen mustard. (1991) (102)
- HYPOTHESIS: THE ENVIRONMENT IS A MAJOR DETERMINANT OF THE IMMUNOLOGICAL SUB‐TYPE OF LYMPHOMA AND ACUTE LYMPHOBLASTIC LEUKAEMIA IN CHILDREN (1982) (102)
- Acute lymphoblastic leukemia in India: an analysis of prognostic factors using a single treatment regimen. (1999) (100)
- Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. II. Surface markers. (1980) (97)
- Histogenetic correlations between subcategories of small noncleaved cell lymphomas. (1992) (95)
- Immunoglobulin secretion by cell lines derived from African and American undifferentiated lymphomas of Burkitt's and non-Burkitt's type. (1982) (94)
- Lymphomas in sub‐Saharan Africa – what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research? (2011) (91)
- Precursor B-Lymphoblastic lymphoma presenting as a solitary bone tumor and mimicking Ewing's sarcoma: a report of four cases and review of the literature. (1998) (91)
- Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma. (1991) (88)
- Burkitt's lymphoma in AIDS: cytogenetic study. (1984) (87)
- Cytogenetic studies in non-African Burkitt lymphoma. (1980) (87)
- Epstein-Barr virus and Burkitt's lymphoma. (1992) (85)
- Molecular epidemiology of Burkitt's lymphoma from South America: differences in breakpoint location and Epstein-Barr virus association from tumors in other world regions (1992) (84)
- Mutations in the coding region of c-myc occur frequently in acquired immunodeficiency syndrome-associated lymphomas. (1994) (84)
- Synthesis of kappa light chains by cell lines containing an 8;22 chromosomal translocation derived from a male homosexual with Burkitt's lymphoma. (1983) (82)
- Structural Barriers to Diagnosis and Treatment of Cancer in Low- and Middle-Income Countries: The Urgent Need for Scaling Up. (2016) (79)
- Epstein-Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells. (2000) (77)
- A mutant p21 cyclin-dependent kinase inhibitor isolated from a Burkitt's lymphoma. (1995) (75)
- Late effects in long-term survivors of high-grade non-Hodgkin's lymphomas. (1998) (74)
- Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics. (1980) (74)
- Switching viral latency to viral lysis: a novel therapeutic approach for Epstein-Barr virus-associated neoplasia. (1996) (73)
- Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis. (1999) (73)
- Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas. (1998) (72)
- Derivation of lymphoma cell lines from microscopically normal bone marrow in patients with undifferentiated lymphomas: evidence of occult bone marrow involvement. (1983) (70)
- Burkitt lymphoma cell line carrying a variant translocation creates new DNA at the breakpoint and violates the hierarchy of immunoglobulin gene rearrangement (1985) (68)
- High frequency of benign mediastinal uptake of gallium-67 after completion of chemotherapy in children with high-grade non-Hodgkin's lymphoma. (1989) (66)
- Epstein-Barr virus (EBV)-associated smooth-muscle tumor arising in a post-transplant patient treated successfully for two PT-EBV-associated large-cell lymphomas. Case report. (1996) (65)
- Bone marrow involvement in young patients with non-Hodgkin's lymphoma: the importance of multiple bone marrow samples for accurate staging. (2006) (65)
- Molecular epidemiology of Burkitt's lymphoma from South America: differences in breakpoint location and Epstein-Barr virus association from tumors in other world regions. (1992) (65)
- CURE OF BURKITT'S LYMPHOMA Ten-year Follow-up of 157 Ugandan Patients (1979) (64)
- Molecular basis of lymphomagenesis. (1992) (63)
- Childhood Kaposi's sarcoma: clinical features and therapy. (1976) (61)
- The investigation of epstein–barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt. Epidemiologic correlations (1995) (61)
- Central nervous system involvement in American Burkitt's lymphoma. (1983) (61)
- CNS involvement in small noncleaved-cell lymphoma: is CNS disease per se a poor prognostic sign? (1991) (60)
- Diagnosis of Burkitt lymphoma using an algorithmic approach – applicable in both resource‐poor and resource‐rich countries (2011) (59)
- The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy. (1987) (58)
- T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals. (1982) (58)
- Lymphocyte differentiation: an essential basis for the comprehension of lymphoid neoplasia. (1981) (57)
- Epstein-Barr virus genotypes in AIDS-associated lymphomas are similar to those in endemic Burkitt's lymphomas. (1992) (56)
- The Role of Surgery in the Management of American Burkitt's Lymphoma and Its Treatment (1982) (56)
- p53 Expression in Langerhans Cell Histiocytosis (1998) (55)
- Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine. (1996) (55)
- Treatment of Burkitt's lymphoma: Randomized clinical trial of single‐agent versus combination chemotherapy (1976) (52)
- Role of the p53 tumor suppressor gene in the tumorigenicity of Burkitt's lymphoma cells. (1997) (51)
- Report of an International Network of Cancer Treatment and Research workshop on non-Hodgkin's lymphoma in developing countries. (2004) (50)
- Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected]. (2005) (50)
- A Review of 37 Patients with Burkitt's Lymphoma (1980) (49)
- A chemiluminescent assay for quantitation of beta-galactosidase in the femtogram range: application to quantitation of beta-galactosidase in lacZ-transfected cells. (1991) (48)
- Treatment of Burkitt lymphoma in equatorial Africa using a simple three‐drug combination followed by a salvage regimen for patients with persistent or recurrent disease (2012) (46)
- Frequencies of the major subgroups of precursor B-cell acute lymphoblastic leukemia in Indian children differ from the West (2003) (44)
- Comparative incidence of the rearrangements of TEL/AML1 and ALL1 genes in pediatric precursor B acute lymphoblastic leukemias in India. (1998) (44)
- Epstein-Barr virus in nasal lymphomas contains multiple ongoing mutations in the EBNA-1 gene. (1998) (43)
- Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimens. (2009) (42)
- Clinical features of Burkitt's lymphoma in the USA. (1985) (42)
- Chemotherapy oif childhood Hodgkin's disease in Uganda. (1972) (42)
- Infrequent p53 mutation in mouse tumors with deregulated myc. (1992) (38)
- Breast cancer: a new Epstein-Barr virus-associated disease? (1999) (38)
- Burkitt's lymphoma between African and American types in Turkish children: clinical, viral (EBV), and molecular studies. (1993) (38)
- Association of Burkitt's Lymphoma with the Epstein-Barr Virus in Two Developing Countries (2000) (37)
- Role of cytoplasmic lipids in altering diphenylhexatriene fluorescence polarization in malignant cells. (1981) (37)
- Regression of experimental Burkitt's lymphoma induced by Epstein-Barr virus-immortalized human B cells. (1994) (37)
- Pattern of Relapse in Childhood ALL: Challenges and Lessons From a Uniform Treatment Protocol (2010) (36)
- Pathogenesis of leukemias and lymphomas : environmental influences (1984) (36)
- Use of Epstein-Barr virus nuclear antigen-1 in targeted therapy of EBV-associated neoplasia. (1996) (36)
- Mouse bcl-3: cDNA structure, mapping and stage-dependent expression in B lymphocytes. (1991) (35)
- CT of American Burkitt lymphoma. (1981) (35)
- Serum monoclonal immunoglobulin bands in undifferentiated lymphomas of Burkitt and non-Burkitt types (1983) (34)
- Cancer in Adolescents and Young Adults in Countries with Limited Resources (2013) (34)
- Comparison of energy metabolism in human normal and neoplastic (Burkitt's lymphoma) lymphoid cells. (1983) (34)
- Serum total and isoenzyme lactate dehydrogenase activity in American Burkitt's lymphoma patients. (1982) (34)
- Bone Involvement in Young Patients With Non-Hodgkin's Lymphoma: Efficacy of Chemotherapy Without Local Radiotherapy (1988) (34)
- The International Cancer Expert Corps: A Unique Approach for Sustainable Cancer Care in Low and Lower-Middle Income Countries (2014) (33)
- Intraclonal molecular heterogeneity suggests a hierarchy of pathogenetic events in Burkitt's lymphoma. (1997) (32)
- A phase II study of ifosfamide in the treatment of recurrent sarcomas in young people (2004) (32)
- Intensive chemotherapy in patients with generalized Burkitt's lymphoma (1972) (31)
- Loss of Y chromosome in bilharzial bladder cancer. (2000) (30)
- Medical Presentations of Choriocarcinoma (1971) (30)
- Induction of plasmacytoid differentiation by phorbol ester in B-cell lymphoma cell lines bearing 8;14 translocations. (1984) (30)
- Localization of breakpoints by polymerase chain reactions in Burkitt's lymphoma with 8;14 translocations. (1990) (29)
- Localization of breakpoints by polymerase chain reactions in burkitt's lymphoma with 8;14 translocations (1990) (29)
- Preliminary report of an intensified, short duration chemotherapy protocol for the treatment of pediatric non-Hodgkin's lymphoma in India. (1997) (29)
- A deletion linked to a poly(ADP-ribose) polymerase gene on chromosome 13q33-qter occurs frequently in the normal black population as well as in multiple tumor DNA. (1990) (29)
- Chromosomal orientation of the lambda light chain locus: Vλ is proximal to Cλ in 22q11 (1985) (29)
- Development of a second clonally discrete Burkitt's lymphoma in a human immunodeficiency virus-positive homosexual patient. (1988) (29)
- Discrepancies in Epstein-Barr virus association at presentation and relapse of classical Hodgkin's disease: impact on pathogenesis. (2000) (28)
- HIGH‐GRADE NON‐HODGKIN'S LYMPHOMA IN PATIENTS WITH AIDS a (1984) (28)
- Immunological phenotypic pattern of acute lymphoblastic leukaemia in Egypt. (1989) (27)
- Biology and treatment of small non-cleaved cell lymphoma. (1989) (27)
- Non-Hodgkin's lymphoma. (1997) (27)
- Targeted approaches to cancer therapy: Meeting held at stone house, NIH, bethesda, md, January 11–12, 1993 (1994) (27)
- Lactate dehydrogenase isoenzymes in normal and malignant human lymphoid cells. (1982) (27)
- Antibodies to Epstein-Barr-virus antigens before and after the development of Burkitt's lymphoma in a patient treated for Hodgkin's disease. (1975) (26)
- Significance of chromosome 8 breakpoint location in Burkitt's lymphoma: correlation with geographical origin and association with Epstein-Barr virus. (1988) (26)
- Replicative viral DNA in Epstein-Barr virus associated Burkitt's lymphoma biopsies. (1993) (26)
- PCR detection of a neutral CGA/CGG dimorphism in exon 6 of the human p53 gene. (1992) (25)
- Lessons from clinical trials in African Burkitt lymphoma (2009) (25)
- Enhancement of Epstein-Barr virus replication in producer cell lines by a combination of low temperature and corticosteroids. (1979) (25)
- Towards Curative Therapy in Burkitt Lymphoma: The Role of Early African Studies in Demonstrating the Value of Combination Therapy and CNS Prophylaxis (2012) (24)
- Surgical resection and limited chemotherapy for abdominal undifferentiated lymphomas. (1984) (23)
- A de novo p53 germline mutation affecting codon 151 in a six year old child with multiple tumors. (1994) (23)
- Combination chemotherapy for advanced bilharzial bladder carcinoma. (1996) (23)
- Drug-induced changes in DNA fluorescence intensity detected by flow microfluorometry and their implications for analysis of DNA content distributions. (1978) (22)
- Infection analysis in acute lymphoblastic leukemia: a report of 499 consecutive episodes in India. (1994) (22)
- A randomized pilot study of high-dose epirubicin as neoadjuvant chemotherapy in the treatment of cancer of the bilharzial bladder. (1991) (22)
- Hypercalcemia with suppressed parathyroid hormone in Burkitt's lymphoma. (1978) (22)
- Phenylbutyrate induces cell differentiation and modulates Epstein-Barr virus gene expression in Burkitt's lymphoma cells. (1999) (22)
- Treatment of patients with high grade non-Hodgkin's lymphomas and central nervous system involvement: is radiation an essential component of therapy? (1996) (21)
- A study of p53 protein, proliferating cell nuclear antigen, and p21 in Hodgkin's disease at presentation and relapse. (1997) (20)
- Myelopathy following intrathecal chemotherapy in a patient with extensive Burkitt's lymphoma and altered immune status. (1985) (19)
- Pattern of immunoglobulin (Ig) and T-cell receptor (TCR) gene rearrangements in childhood acute lymphoblastic leukemia in India. (2000) (19)
- L-asparaginase related hyperglycemia. (1993) (19)
- Childhood T-lineage acute lymphoblastic leukemia: Management and outcome at a tertiary care center in North India (2011) (19)
- A case of proximal 14 trisomy with pathological findings. (2008) (18)
- Targeted approaches to cancer therapy. (1994) (18)
- Differences in the Expression of Apoptotic Proteins in Burkitt's Lymphoma Cell Lines: Potential Models for Screening Apoptosis-Inducing Agents (2004) (17)
- Induction of complement receptor expression in cell lines derived from human undifferentiated lymphomas. II. Characterization of the induced complement receptors and demonstration of the simultaneous induction of EBV receptor. (1981) (16)
- Serial cytogenetic studies of nonendemic Burkitt's lymphoma cell lines. (1980) (16)
- Variable IgH chain enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation. (1993) (16)
- Prognostic-significance of p53 mutations in small non-cleaved cell lymphomas. (1994) (16)
- Burkitt’s Lymphoma: Clinical Aspects and Treatment (1984) (16)
- Limiting therapy for limited childhood non-Hodgkin's lymphoma. (1997) (16)
- Burkitt's lymphoma: a B or T cell tumour? (1974) (15)
- Cancer funding in developing countries: the next health-care crisis? (2010) (15)
- Non‐Hodgkin's Lymphomas: Epidemiology and Treatment (1997) (15)
- Association of EBV Strains, Defined by Multiple Loci Analyses, in Non-Hodgkin Lymphomas and Reactive Tissues from HIV Positive and HIV Negative Patients (2000) (15)
- Epidemiology and management of lymphoma in low‐income countries (2011) (14)
- Complement receptor expression by neoplastic and normal human cells. (1983) (14)
- Significance of MDR1, MRP1, GSTpi and GSTmu mRNA expression in acute lymphoblastic leukemia in Indian patients. (2001) (14)
- It Is Time to Include Cancer and Other Noncommunicable Diseases in the Millennium Development Goals (2009) (14)
- Burkitt's/Burkitt's-like lymphoma presenting as bacterial sinusitis in two HIV-infected children. (2001) (14)
- Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences. (1993) (13)
- Improving cancer care for children and young people 2 Paediatric cancer in low-income and middle-income countries (2013) (13)
- Low incidence of CNS relapse with cranial radiotherapy and intrathecal methotrexate in acute lymphoblastic leukemia. (1996) (12)
- Clinical and Pathobiological Features of Burkitt’s Lymphoma and their Relevance to Treatment (1985) (12)
- Building capacity for cancer control in developing countries: the need for a paradigm shift. (2007) (12)
- Mutations in the Coding Region of c-myc Occur Frequently in Acquired Immunodeficiency Syndrome-Associated Lymphomas (1994) (12)
- Molecular epidemiology of acute lymphoblastic leukemia in Egypt. (1995) (12)
- Treatment of Burkitt lymphoma in children and adults: Lessons from Africa (2006) (11)
- Pediatric oncology in developing countries: development of an alliance of stakeholders. (2001) (11)
- Management of high-grade lymphomas. (1998) (11)
- Epstein-Barr Virus in Nasal Lymphomas Contains Multiple Ongoing Mutations in the EBNA-1 Gene (1998) (11)
- Bone involvement in young patients with non-Hodgkin's lymphoma: efficacy of chemotherapy without local radiotherapy. (1988) (11)
- New Directions in Cancer Treatment (1989) (11)
- Intracerebral Burkitt's lymphoma: pathology, clinical features and treatment. (1974) (11)
- HL-A and Burkitt's tumour--a study in Uganda. (2008) (10)
- Prospects for the therapeutic use of antisense oligonucleotides in malignant lymphomas. (1994) (10)
- Epstein-Barr virus-associated and other antiviral antibodies during intense BCG administration to patients with Burkitt's lymphoma in remission. (1978) (10)
- Absence of germline p53 mutations in familial lymphoma. (1996) (10)
- P53 mutations in egyptian bladder-cancer. (1995) (10)
- Molecular characteristics of diffuse large-B-cell lymphoma. (2002) (9)
- Organization of population-based cancer control programs: Europe and the World (2009) (9)
- Causes of death in patients with burkitt's lymphoma--the role of supportive care in overall management. (1974) (9)
- Classification and Pathogenesis (2010) (9)
- Denis Burkitt and the African lymphoma (2009) (9)
- The molecular analysis of chromosomal translocations as a diagnostic, epidemiological and potentially prognostic tool in lymphoid neoplasia. (1988) (9)
- Expression of EBV Encoded Nuclear Small Non-Polyadenylated RNA (EBER) Molecules in 32 Cases of Childhood Burkitt's Lymphoma from Israel (2001) (9)
- Frequent silencing of fragile histidine triad gene (FHIT) in Burkitt's lymphoma is associated with aberrant hypermethylation (2004) (9)
- Classification of cell lines derived from undifferentiated lymphomas according to their expression of complement and Epstein-Barr virus receptors: implications for the relationship between African and American Burkitt's lymphoma. (1982) (9)
- The treatment of pediatric lymphomas: paradigms to plagiarize? (1997) (9)
- Gastric manifestations of North American Burkitt's lymphoma. (1983) (9)
- Induction of complement receptor expression cell lines derived from human undifferentiated lymphomas. I. Mode of action of theophylline and inhibition by certain purines. (1981) (8)
- Chromosomal orientation of the lambda light chain locus: V lambda is proximal to C lambda in 22q11. (1985) (8)
- CHEMOTHERAPY OF HODGKIN'S DISEASE (1974) (8)
- A novel mutation in the p53 gene in a Burkitt's lymphoma cell line. (1992) (8)
- Infectious Mononucleosis and Malignant Neoplasia (1989) (8)
- Phenotypic analysis of T-cell acute lymphoblastic leukemia in Egypt. (1990) (8)
- Incidence, clinical characteristics and early treatment outcome in Indian patients of childhood acute lymphoblastic leukemia with ALL-1 gene rearrangement. (2001) (8)
- Burkitt cell leukemia without abnormalities of chromosomes No. 8 and 14. (1982) (8)
- Chemotherapy in developing countries--is less better? (2003) (8)
- National Campaign for early diagnosis of retinoblastoma in Brazil (2004) (8)
- Prolonged disease‐free survival in pediatric non‐hodgkin's lymphoma using ifosfamide‐containing combination chemotherapy (2006) (7)
- Skin ulceration caused by Salmonella dublin. (1973) (7)
- The lymphoid neoplasms (2010) (7)
- Burkitt's lymphoma cells frequently carry monoallelic DJ rearrangements. (1992) (7)
- Fc IgM receptors on human lymphoblastoid B cell lines (1978) (7)
- Result of childhood acute lymphoblastic leukemia protocol (INCTR) from a developing country (2007) (7)
- Workshop on pediatric lymphomas: current results and prospects. (1991) (7)
- The World Cancer Declaration: is the world catching up? (2010) (6)
- Aggressive B-Cell Lymphomas (2012) (6)
- Outcome of patients > age 40 with Burkitt lymphoma (BL) treated with aggressive chemotherapuetic regimens : Results from the international Burkitt lymphoma collaborative group (2005) (6)
- Use of fluoresceinated complement-coated bacteria and sheep erythrocyte-antibody-complement complexes for identification of complement receptors on lymphoid cell lines: differences in binding characteristics between cell lines of normal and malignant origin. (1983) (6)
- A comparison of clinical and histopathologic features of childhood malignant lymphoma in Uganda (1974) (6)
- Effects of cyclophosphamide on the mithramycin-DNA fluorescence of human lymphoma cells: a possible result of guanine alkylation. (1979) (6)
- My child matters program: A UICC-sanofi-aventis partnership to improve pediatric cancer care in developing countries (2007) (6)
- Molecular characterization of scl rearrangements in T-cell all from India and egypt. (1993) (6)
- Childhood non-Hodgkin's lymphoma in Egypt: preliminary results of treatment with a new ifosfamide-containing regimen (2004) (6)
- Serum monoclonal immunoglobulin bands in undifferentiated lymphomas of Burkitt and non-Burkitt types. (1983) (6)
- EBNA-1 Sequences in Endemic and Sporadic Burkitt’s Lymphoma (1999) (5)
- Fluorescence polarization as a parameter of plasma lipids in patients with hematologic malignancies. (1983) (5)
- The role of gallium-67 tumour scintigraphy in patients with small, non-cleaved cell lymphoma (1993) (5)
- Bone marrow transplantation for leukaemia: a lame stalking horse for use of high-technology medical care (1995) (5)
- National Campaign for early diagnosis of retinoblastoma in Brazil. (2004) (5)
- Relative predispositional effect of a PADPRP marker allele in B-cell and some non B-cell malignancies. (1990) (5)
- Fine Needle Aspiration in the Diagnosis of Childhood Malignant Disease in Uganda (1973) (5)
- Expression of P53 and Bcl-2 Proteins in T-cell Lymphoblastic Lymphoma: Prognostic Implications (2002) (5)
- Characterization of the Epstein-Barr virus isolated from a cell line derived from a patient with American Burkitt's lymphoma. (1981) (5)
- Intrathecal methotrexate. (1969) (5)
- Abdominal lymphoma mimicking a pancreatic pseudo-cyst. (1982) (4)
- Examination of Epstein-Barr virus and C-type proviral sequences in American and African lymphomas and derivative cell lines. (1981) (4)
- Advances in the Understanding of EBV Associated Lymphoproliferative Disorders (1991) (4)
- Role of the p 53 Tumor Suppressor Gene in Cell Cycle Arrest and Radiosensitivity of Burkitt ' s Lymphoma Cell Lines (2006) (4)
- Apoptotic Death of Tumor Cells Correlates with Chemosensitivity , Independent of p 53 or Bcl-2 (2005) (4)
- B-cell acute lymphoblastic leukemia and Burkitt lymphoma (2006) (4)
- Evaluation of CCNU (NSC-79037) used for the prevention of CNS involvement in Burkitt's lymphoma. (1975) (4)
- Management of histologically aggressive lymphomas with a high risk of CNS disease. (1996) (4)
- Dual reporter vectors for determination of activity of bidirectional promoters. (1992) (4)
- Heterotransplantation of human Burkitt's lymphoma cell lines in athymic nude mice: tumor-host relationships. (1993) (4)
- Expression of surface antigens during the cell cycle in different growth phases of American and African Burkitt's lymphoma cell lines. (1986) (4)
- Towards an international cancer control plan : Policy solutions for the global cancer epidemic (2010) (3)
- Gene Therapy in the Treatment of Cancer: Progress and Prospects (1998) (3)
- Role of the global civil society (2005) (3)
- Persistence of transforming and nontransforming Epstein-Barr virus in high passages of P3HR-1 cell lines. (1982) (3)
- A Phase-II Study of Ifosfamide in the Treatment of Recurrent Sarcomas and Pediatric Tumors (1987) (3)
- Open letter to Lady Scotland. (2017) (3)
- B-Cell Lymphoma/Burkitt Lymphoma (2007) (3)
- Changes in antibodies to Epstein-Barr virus-associated antigens with the development of Burkitt's lymphoma. (1975) (3)
- BCG immunotherapy in Burkitt's lymphoma: preliminary results of a randomized clinical trial. (1973) (3)
- Hodgkin's disease in children 4 years of age or younger. (1992) (3)
- Induction of complement receptors in human cell lines derived from undifferentiated lymphomas. (1981) (2)
- OVERCOMING CHALLENGES IN CONDUCTING CLINICAL TRIALS IN AFRICA (2013) (2)
- NIH conference. A multidisciplinary approach to non-hodgkin's lymphomas. (1981) (2)
- A comparison of clinical and histopathologic features of childhood malignant lymphoma in Uganda. (1974) (2)
- Hypophosphatemia in Burkitt's lymphoma. (1982) (2)
- Childhood Non-Hodgkin’s Lymphomas (1989) (2)
- RESULTS OF A TREATMENT PROTOCOL FOR CHILDREN WITH HIV AND NON-HODGKIN'S LYMPHOMAS (NHLS).: 150 (1997) (2)
- Therapy of localized non-Hodgkin's lymphoma in children. (1984) (2)
- Please redress the balance of millennium development goals (2009) (2)
- Result of Paediatric Non Hodgkin’s Lymphoma with Intensified Short Duration Chemotherapy : A Result from Eastern India (2008) (2)
- Survival of candida septicaemia treated with amphotericin B (1972) (2)
- Editorial comment on detection of Epstein-Barr virus DNA in peripheral blood of paediatric patients with Hodgkin's disease by real-time polymerase chain reaction by Wagner and colleagues. (2001) (1)
- 118INOVERCOMING CANCER IN DEVELOPING COUNTRIES; HOW TO IMPROVE CANCER CARE. (2014) (1)
- Immunoglobulin delta expression in Burkitt's lymphoma cell lines. (1989) (1)
- Corrigendum to “Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year peroid” [Eur J Cancer 41 (2005) 1570–1583] (2007) (1)
- Historical perspective: the evolution of modern concepts of lymphoid neoplasia (2010) (1)
- A rapid screening method for bacteria containing firefly luciferase plasmids. (1993) (1)
- Expression of p53 in pediatric lymphomas from Mexico. (1997) (1)
- An Introduction to Burkitt Lymphoma (2013) (1)
- Characterization of Burkitt’s Lymphoma Cell Lines with Monoclonal Antibodies Using an ELISA Technique (1986) (1)
- Vinblastine Based Short-Pulse B-Non-Hodgkin’s Lymphoma Type Chemotherapy (CT) with Maintenance Therapy Is Highly Efficacious Treatment for Anaplastic Large Cell Lymphoma (ALCL). (2006) (1)
- Management of Burkitt's lymphoma involving the central nervous system. (1976) (1)
- Neo-Adjuvant chemotherapy : Epirubicin in invasive bladder cancer ; four-year follow-up (1991) (1)
- RELAPSE DOSE CHEMOTHERAPY OF BURKITT'S LYMPHOMA IN (1978) (1)
- Endemic Burkitt Lymphoma in second-degree relatives in Northern Uganda: in-depth genome-wide analysis suggests clues about genetic susceptibility (2020) (1)
- Special considerations in low and middle income countries (2012) (0)
- Book Review:The Epstein-Barr Virus. M. A. Epstein, B. G. Achong (1980) (0)
- Epstein-Barr Virus Infection Precedes Clonal Expansion in Burkitt ' s and Acquired Immunodeficiency Syndrome-4 ssociated Lymphoma (2003) (0)
- Preventing cancers by addressing infectious disease (2012) (0)
- The Lymphoid Neoplasms 3ed (2010) (0)
- Inhibition of the EBV Lytic Cycle by Sequence Specific Antisense Oligonucleotides (1991) (0)
- BIS - DISTRIBUTION OF LYMPHOMA SUBTYPES IN SUB-SAHARAN AFRICA (2011) (0)
- immunodeficiency virus-positive homosexual patient Development of a second clonally discrete Burkitt's lymphoma in a human (2012) (0)
- Identification of p53 gene abnormalities in acute lymphoblastic leukemia of childhood (1991) (0)
- of Burkitt and non-Burkitt types Serum monoclonal immunoglobulin bands in undifferentiated lymphomas (2011) (0)
- Prospects for the Development of Antineoplastic Therapy Based on Molecular Pathology (1989) (0)
- Cancer Contrp; in Developing Countries- Paat, Present and Future (2010) (2015) (0)
- Cellular therapies for lymphoma : CATHERINE M BOLLARD, CLIONA M ROONEY AND HELEN E HESLOP (2010) (0)
- Sensitivity to Nitrogen Mustard Apoptosis in Burkitt ' s Lymphoma Cell Lines Differing in Relationship between DNA Cross-Links , Cell Cycle , and Updated (2006) (0)
- Correction of citation in letter on radiotherapy. (1984) (0)
- Author Correction to: Endemic Burkitt lymphoma in second-degree relatives in Northern Uganda: in-depth genome-wide analysis suggests clues about genetic susceptibility (2021) (0)
- General Principles of Management (2010) (0)
- Gene Therapy in the Treatment of Cancer: Preface (1998) (0)
- ALL1 translocation in acute lymphoblastic leukemia in Indian patients (1996) (0)
- from tumors in other world regions differences in breakpoint location and Epstein-Barr virus association Molecular epidemiology of Burkitt's lymphoma from South America: (2011) (0)
- Non‐Hodgkin Lymphomas (2014) (0)
- New Directions in Cancer Treatment: An Overview (1989) (0)
- Planning cancer control--the view of an NGO. (2013) (0)
- Bone-marrow transplantation. (1995) (0)
- Infection as a causal factor of cancer (2012) (0)
- Immunogenetics Immunogenetics: Its Application to Clinical Medicine Takehiko Sasazuki Tomio Tadi (1987) (0)
- Characteristics and results of treatment of non-Hodgkin’s lymphoma in young people — Experience of the Pediatric Branch, NCI, USA (1985) (0)
- Lymphocyte depletion during treatment with intensive chemotherapy (2002) (0)
- Introduction to the lymphoid neoplasms (2010) (0)
- in Prolonged T-Cell Subset Imbalance After Intensive Chemotherapy Distinctions Between CD8+ and CD4+ T-Cell Regenerative Pathways Result (2013) (0)
- Treatment of recurrent sarcomas and pediatric solid tumors with ifosfamide (IF) (1986) (0)
- Future Directions in Diagnosis and Treatment (2010) (0)
- 1241 Impact of improved supportive care on treatment outcome in acute lymphoblastic leukemia—an indian experience (1995) (0)
- Undifferentiated lymphoma cells respond to PWM in the presence of theophylline or helper T cells. (1982) (0)
- Morbidity and mortality from infections in Indian Children with acute leukanias (1998) (0)
- Cytogenetic Studies in Non-African (2017) (0)
- Management of Specific Diseases (2010) (0)
- [Molecular analysis in Argentinian patients with Burkitt's lymphoma]. (1990) (0)
- Survival of 24 Ugandan children with Hodgkin's disease treated by chemotherapy alone. (1975) (0)
- Comprar Gene Therapy in the Treatment of Cancer | Brian E. Huber | 9780521033510 | Cambridge University Press (2007) (0)
- Letter: Chemotherapy of Hodgkin's disease. (1974) (0)
- Diversity of Immunological Phenotypes of Lymphoblastic Lymphoma 1 (2006) (0)
- Gene Therapy in the Treatment of Cancer: Principles of transformation-directed cancer therapy (1998) (0)
- Comprar The Lymphoid Neoplasms 3ed | Ama Rohatiner | 9780340809471 | Hodder Arnold (2009) (0)
- from That of Solid Tumors Mutations in Burkitt ' s Lymphoma Differs p 53 The Pattern of Updated (2006) (0)
- Dysphagia as an unusual manifestation of Burkitt's lymphoma. (1982) (0)
- in Normal and Malignant Human Lymphoid Cells (2017) (0)
- Significance of MDR1, MRP1, GSTp and GSTm mRNA expression in acute lymphoblastic leukemia in (2001) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Ian T. Magrath?
Ian T. Magrath is affiliated with the following schools:
